2021
DOI: 10.1016/j.bja.2021.03.021
|View full text |Cite
|
Sign up to set email alerts
|

Clinical validation of pharmacokinetic/pharmacodynamic models for propofol infusion. Response to Br J Anaesth 2021: 126: e172-4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 10 publications
(16 reference statements)
0
2
0
Order By: Relevance
“…Some authors have suggested that an optimal approach would be required to develop different models for various clinical situations and apply them as appropriate [16]. The drawback of this approach is that it requires substantial scientific knowledge from users and some models may simply not be available in a clinical setting for the diversity of cases [17].…”
Section: When Is a Model Appropriate?mentioning
confidence: 99%
“…Some authors have suggested that an optimal approach would be required to develop different models for various clinical situations and apply them as appropriate [16]. The drawback of this approach is that it requires substantial scientific knowledge from users and some models may simply not be available in a clinical setting for the diversity of cases [17].…”
Section: When Is a Model Appropriate?mentioning
confidence: 99%
“…Recently, the first general purpose model, the Eleveld-model, for propofol became available and was validated in clinical practice [ 69 ]. The Eleveld PK-PD model [ 70 ] is unique in that it can be used for target-controlled infusions in children, adults, older subjects and the obese [ 69 , 71 ].…”
Section: New Pk-pd Models For Existing Anaesthetic Drugs For Tci Appl...mentioning
confidence: 99%